Live GMAT classes with Target Test Prep start Nov 21 and Nov 22. First class free.

See classes
Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

Newsweek Readers’ Choice Awards 2026 winner: Target Test Prep, #1 Test Prep

Target Test Prep was voted #1 Best Test Prep in the 2026 Newsweek Readers’ Choice™ Awards.

★★★★★5.0563 reviews
GMATLiveTeachStarts Nov 22
Josh Braslow, Target Test Prep GMAT expert
LIVE ONLINE CLASSES

Get Ready for GMAT Test Day Faster with Live Online Classes

with Josh Braslow, 20+ years in test prep

Nov 22 · Josh Braslow
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes + 6 months of TTP OnDemand
  • Attend the first class for free
  • Every class is recorded, so you never fall behind
View classes & enroll
Limited seats availableTarget Test Prep
EALiveTeachOnDemandStart anytime
EXECUTIVE ASSESSMENT

Target Test Prep EA OnDemand

Self-paced EA prep. Study on your schedule.

EXECUTIVE ASSESSMENT

with

165+ EA score guarantee
$05-day trial no automatic billing
Schedule
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll Start free 5-day trial
Limited cohort · enrollment openTrial includes full course accessTarget Test Prep
GMATOnDemandStart anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Analysis of an Argument: can you please rate?

Expert replies

How would you rate it?

6
0
No votes
5
0
No votes
4
0
No votes
3
0
No votes
2
0
No votes
1
0
No votes
 
Total votes: 0

by emalby » Sun Mar 20, 2011 8:57 am
The following appeared in an article in a consumer-products magazine:

"Two of today's best-selling brands of full-strength prescription medication for the relief of excess stomach acid, Acid-Ease and Pepticaid, are now available in milder nonprescription forms. Doctors have written 76 million more prescriptions for full-strength Acid-Ease than for full-strength Pepticaid. So people who need an effective but milder nonprescription medication for the relief of excess stomach acid should choose Acid-Ease."

Discuss how well reasoned ... etc.


The argument concludes that people who need an effective but milder nonprescription medication for the relief of excess stomach acid should choose Acid-Ease. The conclusion is based on the premises that doctors have written 76 millions more prescription for full-strenght Acid-Ease than for full-strenght Pepticaid. The argument is logically flawed, however, because it is based on numerous assumptions for which no evidence is given.

The argument assumes that the milder version of the medications shares some of the characteristics with the full-strength medications. This assumption is based on the fact that both the full-strength version and the milder version are used to treat excess stomach acids. However, we do not know anything about the characteristics of the full-strength version compared to those of the milder version.

The argument ignores the possibility that the the reason why more prescriptions for full-strength Acid-Ease have been given than for full-strength Pepticaid is in other reasons than effectiveness. For example one of the reasons could be the price or the availability. Moreover, there is no indication on the period of reference for the data given.

The argument fails to consider that the effectiveness of a full-strength medication can be different from a milder medication even though they are produced from the same company under the same brand or name. In fact, the full-strength medication requires a prescription, while the milder medication does not require a prescription. Therefore the characteristics of the two versions may differ consistently.

In conclusion, the argument that people who need an effective but milder nonprescription medication for the relief of excess stomach acid should choose Acid-Ease is weak. If, for example, additional information on why more prescriptions for the Acid-Ease medication have been written were given, then the argument would be strengthen. Absent this information, however, there is no reason to accept the argument’s conclusion.
Join the discussion
Source: — GMAT Essays (AWA) |